Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
| Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
|---|---|---|---|---|---|---|---|
| BPS-83553 | 2 vials | - | - |
3 - 8 business days* |
9,897.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Firefly Luciferase CD38 Knockout A549 Cell Line is an A549 human lung cancer cell line... more
Product information "Firefly Luciferase CD38 Knockout A549 Cell Line"
Firefly Luciferase CD38 Knockout A549 Cell Line is an A549 human lung cancer cell line constitutively expressing firefly (Photinus pyralis) luciferase under the control of a CMV promoter, where CD38 (Cluster of Differentiation 38) has been genetically removed using CRISPR/Cas9 genome editing with a lentivirus encoding CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human CD38. This cell line was generated by using Firefly Luciferase Lentivirus (#78740-H) on CD38 Knockout A549 Cell LFirefly Luciferase CD38 Knockout A549 Cell Line is an A549 human lung cancer cell line constitutively expressing firefly (Photinus pyralis) luciferase under the control of a EF1A promoter, where CD38 (Cluster of Differentiation 38) has been genetically removed using CRISPR/Cas9 genome editing with a lentivirus encoding CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human CD38. This cell line was generated by using Firefly Luciferase Lentivirus (BPS-78740-H) on CD38 Knockout A549 Cell Line (BPS-82953). This cell line has been validated by genomic sequencing, flow cytometry and luciferase activity.ine (BPS-82953).
| Keywords: | T10, CD38, ADPRC 1, cADPR hydrolase 1, ADP-ribosyl cyclase 1, Cyclic ADP-ribose hydrolase 1, 2'-phospho-ADP-ribosyl cyclase, 2'-phospho-cyclic-ADP-ribose transferase, ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, |
| Supplier: | BPS Bioscience |
| Supplier-Nr: | 83553 |
Properties
| Application: | A549 cell CD38-directed strategy negative control, CD38 knockout phenotype studies |
| Species reactivity: | human |
Database Information
| KEGG ID : | K01242 | Matching products |
| UniProt ID : | P28907 | Matching products |
| Gene ID : | GeneID 952 | Matching products |
Handling & Safety
| Storage: | Liquid nitrogen |
| Shipping: | -80°C (International: °C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed